EAM
TENX icon

EverPoint Asset Management’s Tenax Therapeutics TENX Stock Holding History

EverPoint Asset Management’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$1.46M Buy
23
+12
+109% +$704K 0.03% 348
2016
Q3 		$799K Buy
11
+6
+120% +$473K 0.01% 387
2016
Q2 		$384K Buy
+5
New +$417K 0.01% 363

Other funds holding TENX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return

EverPoint Asset Management's TENX Position: Q4 2016 in Review

EverPoint Asset Management increased its Tenax Therapeutics (TENX) stake by 109% in Q4 2016, buying an estimated $704K and bringing the position to 23 shares worth $1.46M. The position accounts for 0.03% of the portfolio, ranked #348.

EverPoint Asset Management first reported a position in TENX in Q2 2016 and has held it in 3 quarters since. 19 funds tracked by Wall St. Rank hold TENX as of Q4 2016.

  • EverPoint Asset Management held 23 shares of Tenax Therapeutics worth $1.46M as of Q4 2016.
  • EverPoint Asset Management bought 12 Tenax Therapeutics shares in Q4 2016, an estimated $704K.
  • Tenax Therapeutics made up 0.03% of EverPoint Asset Management's portfolio in Q4 2016, its #348 holding.
  • EverPoint Asset Management first reported a position in Tenax Therapeutics in Q2 2016 and has held it in 3 quarters since.
  • 19 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q4 2016.

Based on EverPoint Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.